Clinical trial
The Immunomodulatory Effect of Antrifibrinolytic (Tranexamic Acid) in Total Knee Arthroplasty
NCT03795649 is registered in ClinicalTrials.gov with Sisters of Mercy University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Immunomodulatory Effect of Antrifibrinolytic (Tranexamic Acid) in Total Knee Arthroplasty
- Lead sponsor
- Sisters of Mercy University Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- December 18, 2018
- Completion date
- December 31, 2019
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.